MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

Medicines beginning with T

Tizanidine

Tizanidine 2mg tablets

No stability information

Stability notes for Tizanidine 2mg tablets

There are no stability notes for this medicine.

Suppliers (8) of Tizanidine 2mg tablets
Tizagelan 2mg tablets (G.L. Pharma UK Ltd)
Tizanidine 2mg tablets (A A H Pharmaceuticals Ltd)
Tizanidine 2mg tablets (Alliance Healthcare (Distribution) Ltd)
Tizanidine 2mg tablets (Medihealth (Northern) Ltd)
Tizanidine 2mg tablets (Niche Generics Ltd)
Tizanidine 2mg tablets (Phoenix Healthcare Distribution Ltd)
Tizanidine 2mg tablets (Sigma Pharmaceuticals Plc)
Tizanidine 2mg tablets (Teva UK Ltd)

Tizanidine 4mg tablets

No stability information

Stability notes for Tizanidine 4mg tablets

There are no stability notes for this medicine.

Suppliers (8) of Tizanidine 4mg tablets
Tizagelan 4mg tablets (G.L. Pharma UK Ltd)
Tizanidine 4mg tablets (A A H Pharmaceuticals Ltd)
Tizanidine 4mg tablets (Alliance Healthcare (Distribution) Ltd)
Tizanidine 4mg tablets (Medihealth (Northern) Ltd)
Tizanidine 4mg tablets (Niche Generics Ltd)
Tizanidine 4mg tablets (Phoenix Healthcare Distribution Ltd)
Tizanidine 4mg tablets (Sigma Pharmaceuticals Plc)
Tizanidine 4mg tablets (Teva UK Ltd)

Tizanidine 12mg modified-release capsules

No stability information

Stability notes for Tizanidine 12mg modified-release capsules

There are no stability notes for this medicine.

Supplier

Sirdalud MR 12mg modified-release capsules (Imported (Switzerland))

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.